MS News & Perspectives

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge discusses how ABX-002, Autobahn Therapeutics' experimental treatment for multiple sclerosis, promoted restoration of the myelin sheath.
He also reads “It’s Time to Start Thinking About Seasonal Adjustments and MS" by Beth Ullah, from her column "Through the Looking Glass."=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how among MS patients on rituximab, higher immune B-cell counts are predictive of a better antibody-based response to a COVID-19 vaccine.He also reads “No Crisis, No Column? OK, Fine: Everything Takes So Long With MS” from John Connor's column, "Fall Down, Get Up Again."
=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a registry data study found about half of newly diagnosed RRMS patients burdened by 'hidden' disabilities including fatigue and depression.He also reads “After Standing Still, Finding My Next Step”, from Beth Ullah's column, "Through the Looking Glass."=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

As a Physical Therapist & Multiple Sclerosis Specialist, Dr.Gretchen Hawley FT, DFT, MSCS is passionate about helping people with multiple sclerosis gain strength, mobility, and independence. Listen in as Jenn and Dr. Hawley discuss the online MS wellness program, The MSing Link, what inspired Dr. Hawley to specialize in MS, and the creative ways you can seek wellness. Join the conversation on our MS forums: http://www.multiplesclerosisnewstoday.com/forums/ Follow us on social media:
Instagram - http://www.instagram.com/msnewstoday/
Facebook - http://www.facebook.com/multiplesclerosisnewstoday/
Twitter - http://www.twitter.com/msnewstoday

For more news on Multiple Sclerosis visit:
http://www.multiplesclerosisnewstoday.com/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how findings suggest that disease severity, brain volume loss, and brain lesions are able to predict later cognitive declines in people with RRMS.He also reads “Hunt for EBV Vaccine Gets a Boost From NIH”, from Ed Tobias' column, "The MS Wire."=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/

Our #31DaysOfMS campaign has shined the spotlight on the MS community for the last four weeks. To wrap things up, we invited Arelis Castillo and Desiree Lama, two of our MS News Today moderators, to join us in a conversation about the experience of working behind the 31 Days campaign. Listen to this conversation with Arelis and Desiree here and be sure to read all of the #31DaysOfMS stories on our website: https://bit.ly/3MdMwwy

#MSawareness #multiplesclerosis #MS

Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/

Our #31DaysOfMS campaign offers many experiences! We have organized a live event for you to meet two of the campaign’s contributors, Tyler Campbell and Laurie Lambert. This chat on all things MS was hosted by our very own Ally Macgregor. Listen to this conversation with Tyler Campbell and Laurie Lambert here and be sure to read their stories on our MS News Today website.Tyler's story: https://bit.ly/3P5o4iX
Laurie's story: https://bit.ly/39GUT5h

Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/

Our #31DaysOfMS is shedding a light on the different ways our community does life with MS. Carolyn Hinds, one of the campaign’s contributors, chatted to us live about her own experience. This chat on all things MS was hosted by our very own Ally Macgregor. Listen to this conversation with Carolyn Hinds here and be sure to read her full story on our MS News Today website: https://bit.ly/39egrpD

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reports on how Canadians with multiple sclerosis said cannabis was highly effective in treating sleep issues, pain, stress, fatigue, and muscle spasms.He also reads “MS News That Caught My Eye Last Week: Cannabis, Keto Diet, Tysabri, MS Unknowns”, from Ed Tobias' column, "The MS Wire."=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about a finding that could lead to treatment approaches that would instruct the immune system to "tolerate" the molecules wrongly targeted in MS.He also reads the latest article on our Expert Voices series, which focuses on the use of cannabis in people with multiple sclerosis.===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/